BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2697408)

  • 1. Autologous BMT for AML without purging.
    Burnett AK
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():76-8. PubMed ID: 2697408
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous bone marrow transplantation in first remission AML--its relative value.
    de Gast GC; Zwaan FE; Hagenbeek T; Verdonck LF; Löwenberg B
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():52-4. PubMed ID: 2202468
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of autologous bone marrow transplantation for acute leukaemia.
    Gulati SC; Whitmarsh K; Reich L; Berman E; Yahalom J; Yopp J; Clarkson B; Gee T
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():61-4. PubMed ID: 2697438
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol.
    Zittoun R; Mandelli F; De Witte T; Willemze R; Tura S
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():56-8. PubMed ID: 2202470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autotransplantation in acute nonlymphoid leukemia].
    Meloni G; Mandelli F
    Haematologica; 1991 Jun; 76 Suppl 3():321-6. PubMed ID: 1752528
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia and the position of autologous stem cell transplantation.
    Breems DA; Löwenberg B
    Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of intensive consolidation therapy and autologous bone marrow transplantation in acute myeloid leukaemia. The Leiden experience.
    Willemze R; Fibbe WE; Richel DJ; Kluin-Nelemans JC; Zwaan FE
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():73. PubMed ID: 2697407
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
    Gulati SC; Shank B; Sarris A; Berman E; Gee T; Cunningham I; Flomenberg N; O'Reilly RJ; Clarkson B
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in patients with AML in second complete remission (CR).
    Meloni G; De Fabritiis P; Amadori S; Petti MC; Pulsoni A; Sandrelli A; Mandelli F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():207-8. PubMed ID: 2653505
    [No Abstract]   [Full Text] [Related]  

  • 11. High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?
    Dicke KA; Spinolo JA
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():184-6. PubMed ID: 2653500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double intensification including autologous bone marrow transplantation (ABMT) in AML: long term follow-up and detection of residual disease.
    Dicke KA; Dicke-Evinger MJ; Spinolo JA; Estey EH; Kantarjian HM; Spitzer GS
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():27-34. PubMed ID: 2390639
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
    Bernasconi C; Lazzarino M; Canevari A; Morra E; Castelli G; Brusamolino E; Alessandrino EP; Pagnucco G; Orlandi E; Castagnola C
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic BMT for AML in Zagreb.
    Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
    Suciu S; Solbu G; Zittoun R; Hayat M; Willemze R; de Witte T; Mandelli F
    Bone Marrow Transplant; 1991; 7 Suppl 2():34. PubMed ID: 1878707
    [No Abstract]   [Full Text] [Related]  

  • 16. Post remission therapy in acute myeloid leukaemia (AML): the Medical Research Council experience in the UK.
    Rees JK; Gray RG
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():70-1. PubMed ID: 2697405
    [No Abstract]   [Full Text] [Related]  

  • 17. Double autologous bone marrow transplantation in acute myeloid leukaemia.
    Gribben JG; Goldstone AH; Linch DC; MacMillan AK; Richards JD
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():209-11. PubMed ID: 2653506
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies of allogeneic marrow transplantation in patients with acute non-lymphoblastic leukaemia. Seattle Marrow Transplant Team.
    Buckner CD; Clift RA
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():82. PubMed ID: 2697410
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous BMT for ALL.
    Burnett AK
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():79-80. PubMed ID: 2697409
    [No Abstract]   [Full Text] [Related]  

  • 20. Purging procedures for acute leukaemias in autologous BMT.
    Rizzoli V; Mangoni L; Carella AM; Coleselli P; Angrilli F; Alessandrino EP; Miniero A; Novarino A; Falda M; Mozzana R
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():77-80. PubMed ID: 2697443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.